SYRS News and Press, Syros Pharmaceuticals Inc. From 01/23/20

Syros Pharmaceuticals ( SYRS ) is a small cap, clinical stage pharmaceutical company. As such it carries all the risks and potentials to the category. Mainly, if its drugs fail to gain regulatory approval, it will turn out to be a bad investment. If one or more drugs gain regulatory approval, ...

Amedisys (NASDAQ: AMED ) initiated with Outperform rating and $206 (14% upside) price target at Credit Suisse. More news on: Amedisys, Inc., BeiGene, Ltd., Karyopharm Therapeutics Inc., Healthcare stocks news, , Read more ...

Gainers: XPO   +15.6% . OSMT   +15.1% . SYRS   +3.1% . SAVE   +2.1% . CRSP   +1.9% . More news on: XPO Logistics, Inc., Osmotica Pharmaceuticals plc, Syros Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Shares of Syros Pharmaceuticals (NASDAQ: SYRS) are soaring today, up by 15.7% as of 11:04 a.m. EST, after the company announced that Mark Alles is joining its board of directors. Alles previously served as CEO of Celgene prior to its acquisition by Bristol-Myers Squibb . The appointment of...

Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced the appointment of Mark Alles to the Company’s Board of Directors. Mr. Alles is a recognized biopharmaceutical executive with a proven record of building...

CAMBRIDGE, Mass. , Dec. 19, 2019 /PRNewswire/ --   Flagship Pioneering, a unique life sciences innovation enterprise, today announced the launch of Ring Therapeutics, an early-stage biotechnology company developing first-in-class gene therapies using a new viral vector platform based...

Gainers:  Inpixon (NASDAQ: INPX ) +68% . More news on: Inpixon, Mirum Pharmaceuticals, Inc., YayYo, Inc., Stocks on the move, Read more ...

Syros Pharmaceuticals (NASDAQ: SYRS ) ( +6%  premarket) and Global Blood Therapeutics (NASDAQ: GBT ) ( -6%  premarket) will collaborate to discover, develop and commercialize new treatments for sickle cell disease and beta thalassemia. More news on: Syros Pharmaceuticals, Inc.,...

YayYo (NASDAQ: YAYO ) +39%  on entering into a new fleet partnership with LMP Automotive Holdings. More news on: YayYo, Inc., Solid Biosciences Inc., ASLAN Pharmaceuticals Limited, Stocks on the move, Read more ...

Balance Sheet Strengthened to Support Pipeline Advancement and Oxbryta™ (voxelotor) Commercialization SOUTH SAN FRANCISCO, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it has entered into a $150 million loan ag...